Morphine News and Research

Latest Morphine News and Research

TheraQuest's IND for abuse deterrent strong opioid (TQ-1015) accepted by FDA

TheraQuest Biosciences, Inc. a development stage pain management company today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug ("IND") application for TQ-1015, its abuse deterrent extended release strong opioid. TQ-1015 is being developed using Securel, TheraQuest's proprietary abuse deterrent technology.

13 Nov 2008

CutisPharma issued patent for suppository compounding

CutisPharma, Inc. has announced that it has received approval from the United States Patent and Trademark Office for its patent (US 7,434,690) regarding a container and kit for the preparation, storage and dispensing of compounded suppositories.

7 Nov 2008

Extended suboxone treatment substantially improves outcomes for opioid-addicted young adults

In the first clinical trial of a medication that was used for an extended time to treat opioid addiction in young adults, participants who received counseling and Suboxone (buprenorphine-naloxone) for 12 weeks had substantially better outcomes than those who received the standard treatment of short-term detoxification and counseling.

4 Nov 2008

Long-term benefits of morphine treatment in infants confirmed

A recent study conducted by researchers at Georgia State University is the first of its kind to demonstrate that administration of preemptive morphine prior to a painful procedure in infancy blocks the long-term negative consequences of pain in adult rodents.

4 Nov 2008

New cannabis-like drugs could block pain without affecting brain

A new type of drug could alleviate pain in a similar way to cannabis without affecting the brain, according to a new study published in the journal Pain on Monday 15 September.

15 Sep 2008

Diazepam effects nerve cells in the brain reward system

Addictions to medicines and drugs are thought to develop over a relatively long period of time. The process involves both structural and functional changes in brain nerve cells that are still poorly understood.

27 Aug 2008

Codeine use may be risky for some breastfeeding mothers

Using pain treatments which contain codeine may be risky for some breastfeeding mothers, according to researchers at The University of Western Ontario, and the Hospital for Sick Children (SickKids) in Toronto.

20 Aug 2008

Abiraterone new drug for aggressive prostate cancer the best thing in 70 years

Scientists say a new drug which treats aggressive prostate cancer is possibly the most significant development in the field for 70 years.

22 Jul 2008

How best to treat chronic pain? The jury is still out

How best to alleviate chronic pain, a leading cause of disability and employee absenteeism, continues to perplex both patients and their doctors.

5 Jun 2008

Boost for cancer research in Leicestershire

A new approach to pain relief, investigation of a gene that triggers colorectal cancer and the prevention, early diagnosis and treatment of ovarian cancer are three research projects at the University of Leicester, which are to benefit from funding from the Leicestershire and Rutland charity Hope Against Cancer.

21 May 2008

Noninvasive ventilation eases final hours, days for lung cancer patients

For patients with end-stage lung cancer, noninvasive ventilation (NIV) may be more effective at reducing breathing difficulty than standard oxygen therapy, and has the added advantage of reducing patients' reliance on morphine, thus improving lucidity in their final days, according to research presented at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.

20 May 2008

FDA approves Entereg (alvimopan) to restore bowel function

The U.S. Food and Drug Administration approved Entereg (alvimopan) today to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery. Entereg will be used in hospitalized patients who can receive no more than 15 doses.

20 May 2008

Platypus venom linked to pain relief

New research released today in the scientific research journal Nature reveals links between platypus venom and its potential benefits for advancing pain relief and antibiotic medication

7 May 2008

FDA approves Relistor for opioid-induced constipation - helps reduce effects of drugs like morphine on bowel function

The U.S. Food and Drug Administration today approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain.

24 Apr 2008

Popular painkiller Nurofen Plus in danger of becoming a prescription only drug

Australia's National Drugs and Poisons Scheduling Committee (NDPSC) is apparently considering making one of the most commonly used over-the-counter (OTC) drugs available only with a prescription.

15 Apr 2008

Nurses accused of manslaughter plead not guilty

The nurses 48 year-old Jennifer Annique Valentine of Reedy Creek and 51-year-old Michael George Gibbons of Hope Island, allegedly failed to alert doctors to an emergency situation and as a result a patient died.

9 Apr 2008

Oral methadone dosing for chronic pain: practitioner's guide

Methadone, a strong opioid analgesic, is an effective and economical choice for the management of cancer pain and chronic noncancer pain, both as a first line medication and as a replacement opioid.

14 Mar 2008

Influencing factors and recommendations that enhance the autonomy of cancer patients in clinically terminal situations

The PhD, defended by Ana María Martínez Fernández at the University of the Basque Country, proposes a series of recommendations that contribute to improving clinical and care tasks of the professionals who treat terminal cancer patients.

4 Mar 2008

Australian neuroscientist tests Chantix

UQ pharmacy graduate Dr Selena Bartlett is starting clinical trials of a new drug that could potentially curb addictions such as smoking, drinking, gambling even depression.

20 Feb 2008

Chronic pain is a disease in its own right

The concept that chronic pain is a disease in its own right is leading to new specific treatments aimed at physical, psychological, and environmental components of this major disease, including genetic predisposition, according to a world renowned pain medicine expert.

17 Feb 2008